MoonLake Immunotherapeutics 2024 AGM: all director nominees elected, say-on-pay approved, annual frequency adopted

MoonLake Immunotherapeutics

Director nominees Catherine Moukheibir (50.4M for) and Dr. Ramnik Xavier (53.9M for) elected; 4.24M broker non-votes.
Baker Tilly ratified as independent auditor with 52.6M for vs 6.4M abstentions.
Advisory vote on executive compensation passed with 54.7M for (99.99% of votes cast).
Advisory vote on frequency: 54.2M chose 1 year; company will hold annual say-on-pay votes going forward.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.